MacuLogix has established a $25,000 MacuLogix AMD Advocacy endowed award at Salus University Pennsylvania College of Optometry. PCU/Salus University was chosen for this award...
Reports indicate that a staggering 78 percent of patients are first diagnosed with age-related macular degeneration (AMD) having already suffered irreversible vision loss.